Elbe Pharma Nigeria Limited Pharmaceutical Import Profile — Nigeria (DGFT 2022–2026)

Name: Elbe Pharma Nigeria Limited Pharmaceutical Import Records from India — 3 Products, $3.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Elbe Pharma Nigeria Limited — Pharmaceutical Importer Profile (2026) | 3 Products, $3.3M Trade | TransData Nexus

Elbe Pharma Nigeria Limited

Pharmaceutical Importer · Nigeria · Antimalarial & Antiparasitic Focus · $3.3M Total Trade · DGFT Verified

Elbe Pharma Nigeria Limited is a pharmaceutical importer based in Nigeria with a total trade value of $3.3M across 3 products in 3 therapeutic categories. Based on 77 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Elbe Pharma Nigeria Limited sources from 10 verified Indian suppliers, with Olive Health Care accounting for 66.5% of imports.

Elbe Pharma Nigeria Limited — Import Portfolio & Supplier Network

Elbe Pharma Nigeria Limited import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Elbe Pharma Nigeria Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Olive Health Care	$5.0M	127	66.5%
Olive Healthcare	$920.8K	19	12.1%
Olive Pharmascience Private Limited	$643.8K	13	8.5%

What Formulations Does Elbe Pharma Nigeria Limited Import?

Formulation	Value	Ships
Pharmaceutical products amatem forte	$650.0K	13
Pharmaceutical products: amatem forte softgel Each soft gelatin capsule contains :artemether ph. int. 80 MG	$400.0K	8
Pharmaceutical products amatem forte softgel Each soft gelatin capsule contains artemether ph. int. 80 MG.	$298.0K	6
Pharmaceutical products 1. amatem forte softgel Each soft gelatin capsule contains artemether ph. int. 80	$297.9K	6
Pharmaceutical products 1. amatem forte softgel ,Each soft gelatin capsule contains artemether ph. int. 80	$297.6K	6
Pharmaceutical products 1. amatem softgel 20/120 Each soft gelatin capsule contains artemether ph. int. 20	$259.6K	6
Pharmaceutical products amatem	$200.0K	4
Pharmaceutical products daravit man	$200.0K	4
Pharmaceutical products daravit man	$200.0K	4
Pharmaceutical article / ods / product / item amatem forte	$200.0K	4
Pharmaceutical productsdaravit	$200.0K	8
Pharmaceutical article / ods / product / item amatem	$196.3K	4
Pharmaceutical products amatem	$150.0K	3
Pharmaceutical products :amatem forte softgel-Each soft gelatin capsule contains:artemether ph. int.80 MG.	$150.0K	3
Pharmaceutical products amatem forte softgel Each soft gelatin capsule containsartemether ph.int.80 mglumefantrine	$149.0K	3

Elbe Pharma Nigeria Limited imports 104 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Artemether	Antimalarial & Antiparasitic	$3.0M	60	0.3%	7
2	Extract	Ayurvedic & Herbal Products	$200.0K	4	1.6%	6
3	Omega	Nutritional Supplements	$122.1K	13	0.6%	12

Elbe Pharma Nigeria Limited imports 3 pharmaceutical products across 3 categories into Nigeria totaling $3.3M.

Elbe Pharma Nigeria Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Elbe Pharma Nigeria Limited is a prominent pharmaceutical company headquartered in Lagos, Nigeria. With over 30 years of experience in the healthcare industry, the company has established itself as a trusted provider of high-quality and affordable pharmaceutical products, encompassing both branded and generic formulations. Their product portfolio spans various therapeutic categories, including antimalarials, anti-infectives, vitamin and mineral supplements, and topical creams.

The company's mission is to be the most valued pharmaceutical partner in the healthcare sector by providing quality, affordable, and accessible products. Their vision is to deliver premier brands that promote healthy living for all, aiming to emerge as a domestic leader in the pharmaceutical industry.

2Distribution Network

Elbe Pharma Nigeria Limited operates from its headquarters at 1 African Church Close, Ilupeju, Lagos. While specific details about their warehouse locations and logistics capabilities are not publicly disclosed, the company's extensive distribution network ensures that their products are available across Nigeria. This widespread availability indicates a robust logistics infrastructure capable of meeting the demands of the Nigerian market.

3Industry Role

Elbe Pharma Nigeria Limited plays a significant role in Nigeria's pharmaceutical supply chain as a primary wholesaler and distributor. By importing a diverse range of pharmaceutical products, including antimalarials, anti-infectives, and nutritional supplements, the company ensures a steady supply of essential medications to various healthcare providers across the country. Their focus on both branded and generic products allows them to cater to a broad spectrum of market needs, reinforcing their position as a key player in the domestic pharmaceutical industry.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Elbe Pharma Nigeria Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Elbe Pharma Nigeria Limited demonstrates a high degree of sourcing concentration, with a total import value of $3.3 million USD from India across 77 shipments. The top five products imported are Artemether ($3.0 million, 0.3% share), Extract ($200K, 1.6% share), and Omega ($122K, 0.6% share). This concentration suggests a strategic choice to source specific products from India, likely due to favorable pricing, quality, or supplier reliability.

The company's reliance on a limited number of suppliers, particularly from India, indicates a potential risk in terms of supply chain disruptions. However, the consistent volume of shipments and the significant value of imports suggest a stable and well-established relationship with these suppliers. This stability is crucial for maintaining uninterrupted product availability in the Nigerian market.

2Supply Chain Resilience

Elbe Pharma Nigeria Limited's supply chain resilience is closely tied to its sourcing strategy from India. The company's import data reveals a diversified supplier base, with ten unique suppliers contributing to the total import value. Notably, Olive Health Care accounts for 66.5% of the total import value, indicating a dominant supplier relationship. This concentration could pose risks if disruptions occur with this primary supplier.

The company's import portfolio includes 104 unique formulations, reflecting a diverse product range. This diversity can mitigate risks associated with over-reliance on a single product line. However, the heavy reliance on a few key suppliers underscores the importance of maintaining strong relationships and having contingency plans in place to address potential supply chain disruptions.

Importing Pharmaceuticals into Nigeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nigeria

1Regulatory Authority & Framework

In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) serves as the primary regulatory authority overseeing the importation, distribution, and marketing of pharmaceutical products. NAFDAC ensures that all pharmaceutical products meet the required safety, efficacy, and quality standards before they are permitted for sale in the Nigerian market.

The regulatory framework governing pharmaceutical imports includes the NAFDAC Act CAP N1 (LFN) 2004 and other related legislation. These regulations stipulate that no drug shall be manufactured, imported, exported, advertised, sold, distributed, or used in Nigeria unless it has been registered in accordance with the provisions of the NAFDAC Act and accompanying guidelines. (nafdac.gov.ng)

2Import Licensing & GMP

Importers of pharmaceutical products into Nigeria are required to obtain an import license from NAFDAC. This process involves submitting a dossier of the drug product for screening, which is a prerequisite for the registration of pharmaceutical products for human use. The application for registration should be processed on the NAFDAC Automated Product Administration and Monitoring System (NAPAMS) portal. (nafdac.gov.ng)

NAFDAC recognizes Good Manufacturing Practice (GMP) certificates from reputable international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications are essential for ensuring that imported pharmaceutical products meet the required quality standards.

Elbe Pharma Nigeria Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Elbe Pharma Nigeria Limited's focus on importing antimalarials, anti-infectives, and nutritional supplements aligns with the prevalent health challenges in Nigeria. Malaria remains a significant public health issue, necessitating a consistent supply of effective antimalarial medications. The emphasis on anti-infectives addresses the ongoing need for treatments against various infectious diseases. Nutritional supplements cater to the dietary needs of the population, supporting overall health and wellness.

The company's import strategy is driven by market demand, aiming to provide essential healthcare products that are both effective and affordable. By sourcing these products from India, Elbe Pharma leverages cost advantages and supplier expertise, enabling them to offer a diverse product range that meets the needs of the Nigerian market.

2Sourcing Profile

Elbe Pharma Nigeria Limited's sourcing strategy is centered on importing finished pharmaceutical formulations from India. This approach allows the company to offer a wide range of products without the complexities associated with manufacturing. The focus on finished formulations ensures that the company can provide ready-to-use products that meet the quality standards required by Nigerian consumers.

India's well-established pharmaceutical industry, known for its adherence to international quality standards, makes it a preferred sourcing destination for Elbe Pharma. The company's import data indicates a diversified supplier base, with ten unique suppliers contributing to the total import value, reflecting a strategic approach to sourcing that balances supplier reliability with cost considerations.

Seller's Guide — How to Become a Supplier to Elbe Pharma Nigeria Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Nigerian market by partnering with Elbe Pharma Nigeria Limited. The company's established distribution network and market presence provide a solid platform for introducing new products. Potential gaps in Elbe Pharma's current sourcing include specific therapeutic areas or product forms that are in demand but not yet part of their portfolio.

Indian exporters can explore these opportunities by understanding the unmet needs in the Nigerian market and aligning their product offerings accordingly. Collaborating with Elbe Pharma can facilitate market entry and expansion, leveraging the company's expertise and established relationships within Nigeria's pharmaceutical sector.

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Elbe Pharma Nigeria Limited

What products does Elbe Pharma Nigeria Limited import from India?

Elbe Pharma Nigeria Limited imports 3 pharmaceutical products across 3 categories. Top imports: Artemether ($3.0M), Extract ($200.0K), Omega ($122.1K).

Who supplies pharmaceuticals to Elbe Pharma Nigeria Limited from India?

Elbe Pharma Nigeria Limited sources from 10 verified Indian suppliers. The primary supplier is Olive Health Care (66.5% of imports, $5.0M).

What is Elbe Pharma Nigeria Limited's total pharmaceutical import value?

Elbe Pharma Nigeria Limited's total pharmaceutical import value from India is $3.3M, based on 77 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Elbe Pharma Nigeria Limited focus on?

Elbe Pharma Nigeria Limited imports across 3 categories. The largest: Antimalarial & Antiparasitic (90.3%), Ayurvedic & Herbal Products (6.0%), Nutritional Supplements (3.7%).

Get Full Elbe Pharma Nigeria Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.